MitoRx Therapeutics

BiotechnologySeedOxford, UKmitorxtherapeutics.com

Latest round

Seed

Last raised

Mar 2023

Total raised

$5.2M

Investors

6

About MitoRx Therapeutics

Based in Oxfordshire, UK, and founded in 2021, MitoRx Therapeutics Limited provides medicines that stop the course of degenerative diseases caused by the mitochondrial malfunction.48 million post-money. The company was founded by Jon Rees (CEO), Norman Law, and Prof. Matt Whiteman. The company offers ideal mitochondrial medicine which helps in arresting the progression of degenerative diseases caused by mitochondrial dysfunction which includes mainly metabolic diseases, and neurodegenerative diseases. The firm technology mediates sulfide-signaling that has the effect of substrate replenishment in the state of trans–sulfuration deficiency.

Who invested in MitoRx Therapeutics

6 investors across 2 rounds

See all investors in MitoRx Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Mar 31, 2023

    Amount

    $3.1M

    Investors

    Locked

  2. Seed

    Nov 11, 2021

    Amount

    $2.1M

    Investors

    Locked

Questions about MitoRx Therapeutics

Who invested in MitoRx Therapeutics?

MitoRx Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has MitoRx Therapeutics raised?

MitoRx Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did MitoRx Therapeutics last raise money?

MitoRx Therapeutics's most recent round on record is a Seed, in Mar 2023.

What does MitoRx Therapeutics do?

Based in Oxfordshire, UK, and founded in 2021, MitoRx Therapeutics Limited provides medicines that stop the course of degenerative diseases caused by the mitochondrial malfunction.

Where is MitoRx Therapeutics headquartered?

MitoRx Therapeutics is headquartered in Oxford, UK.

Which VCs invest in companies like MitoRx Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at MitoRx Therapeutics's stage. Their profiles are linked below.

Raising like MitoRx Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.